Rui Kang Pharmaceutical Group Investments Limited (the “Company”) was established in 1996 as a Sino-foreign joint equity venture in the People’s Republic of China and was listed on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited in June 2004.

The Company is an investment holding company and the principal activities of its subsidiaries include (i) manufacture, research and development, sale and distribution of health related and pharmaceutical products in the People's Republic of China and Hong Kong; (ii) provision of medical laboratory testing services and health check services in Hong Kong and (iii) trading securities in Hong Kong.